Cash flow Beacon Pharmaceuticals PLC

Revenues

Cost of Goods Sold, Total

Selling General & Admin Expenses, Total

Other Operating Expenses, Total

Interest Expense, Total

Interest And Investment Income

Net Interest Expenses

Currency Exchange Gains (Loss)

Other Non Operating Income (Expenses)

Gain (Loss) On Sale Of Investments

Gain (Loss) On Sale Of Assets

Income Tax Expense

Net Income to Company

Net Income to Common Incl Extra Items

Net Income to Common Excl. Extra Items

Net EPS - Basic

Basic EPS - Continuing Operations

Basic Weighted Average Shares Outstanding

Net EPS - Diluted

Diluted EPS - Continuing Operations

Diluted Weighted Average Shares Outstanding

Normalized Basic EPS

Normalized Diluted EPS

Dividend Per Share

Payout Ratio

EBITDA

EBITA

EBIT

EBITDAR

Effective Tax Rate - (Ratio)

Current Domestic Taxes

Total Current Taxes

Deferred Domestic Taxes

Total Deferred Taxes

Normalized Net Income

Interest on Long-Term Debt

Non-Cash Pension Expense

Advertising Expense

Marketing Expenses

Selling and Marketing Expenses

General and Administrative Expenses

Research And Development Expense From Footnotes

Net Rental Expense, Total

Imputed Operating Lease Interest Expense

Imputed Operating Lease Depreciation

Maintenance & Repair Expenses, Total

Cash And Equivalents

Short Term Investments

Accounts Receivable, Total

Other Receivables

Notes Receivable

Inventory

Deferred Tax Assets Current

Other Current Assets, Total

Gross Property Plant And Equipment

Accumulated Depreciation

Long-term Investments

Other Long-Term Assets, Total

Accounts Payable, Total

Accrued Expenses, Total

Short-term Borrowings

Current Portion of Long-Term Debt

Current Portion of Leases

Current Income Taxes Payable

Unearned Revenue Current, Total

Deferred Tax Liability Current

Other Current Liabilities

Long-Term Debt

Long-Term Leases

Deferred Tax Liability Non Current

Common Stock, Total

Retained Earnings

Comprehensive Income and Other

Total Common Equity

ECS Total Shares Outstanding on Filing Date

ECS Total Common Shares Outstanding

Book Value / Share

Tangible Book Value

Tangible Book Value Per Share

Total Debt

Net Debt

Debt Equivalent Oper. Leases

Account Code - Inventory Valuation

Inventories - Raw Materials, Total

Inventories - Work In Process, Total

Inventories - Finished Goods, Total

Inventories - Others

Land - (BS)

Buildings, Total

Machinery, Total

Full Time Employees

Return on Assets

Return on Total Capital

Return On Equity %

Return on Common Equity

Gross Profit Margin %

SG&A Margin

EBITDA Margin %

EBITA Margin %

EBIT Margin %

Income From Continuing Operations Margin %

Net Income Margin %

Net Avail. For Common Margin %

Normalized Net Income Margin

Levered Free Cash Flow Margin

Unlevered Free Cash Flow Margin

Asset Turnover

Fixed Assets Turnover

Receivables Turnover (Average Receivables)

Inventory Turnover (Average Inventory)

Current Ratio

Quick Ratio

Operating Cash Flow to Current Liabilities

Days Sales Outstanding (Average Receivables)

Days Outstanding Inventory (Average Inventory)

Average Days Payable Outstanding

Cash Conversion Cycle (Average Days)

Total Debt/Equity

Total Debt / Total Capital

LT Debt/Equity

Long-Term Debt / Total Capital

Total Liabilities / Total Assets

EBIT / Interest Expense

EBITDA / Interest Expense

(EBITDA - Capex) / Interest Expense

Total Debt / EBITDA

Net Debt / EBITDA

Total Debt / (EBITDA - Capex)

Net Debt / (EBITDA - Capex)

Total Revenues, 1 Yr. Growth %

Gross Profit, 1 Yr. Growth %

EBITDA, 1 Yr. Growth %

EBITA, 1 Yr. Growth %